BETA


2019/2826(RSP) Resolution on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron

Progress: Procedure completed

RoleCommitteeRapporteurShadows
Lead ENVI HAZEKAMP Anja (icon: GUE/NGL GUE/NGL) TRILLET-LENOIR Véronique (icon: Renew Renew)
Lead committee dossier:
Legal Basis:
RoP 112-p2

Events

2019/10/10
   EP - Motion for a resolution
Documents
2019/10/10
   EP - Decision by Parliament, 1st reading/single reading
Details

The European Parliament adopted by 402 votes to 222, with 39 abstentions, a resolution objecting to the Commission Implementing Regulation on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanatemethyl, triflusulfuron and tritosulfuron.

Parliament considered that the draft Commission implementing regulation does not respect the precautionary principle. According to Members, the decision to extend the approval period for chlorotoluron is not in line with the safety criteria laid down in Regulation (EC) No 1107/2009, and is based neither on evidence that this substance can safely be used, nor on a proven urgent need for the active substance chlorotoluron in food production in the Union.

In support of its objection, Parliament stated that, according to Regulation (EC) No 1272/2008 of the European Parliament and of the Council, chlorotoluron has a harmonised classification of very toxic to aquatic life, very toxic to aquatic life with long lasting effects, suspected of causing cancer, and suspected of damaging the unborn child.

Moreover, in 2015 chlorotoluron was placed on the ‘list of candidates for substitution’ by Commission Implementing Regulation (EU) 2015/408 because it is considered to have endocrine-disrupting properties that may cause adverse effects in humans, and because it meets the criteria for it to be considered a persistent and toxic substance.

Members considered it is unacceptable that a substance which is known to meet the cut-off criteria for active substances that are mutagenic, carcinogenic and/or toxic for reproduction or that have endocrine-disrupting properties, which are set to protect human and environmental health, continues to be allowed for use in the Union, putting public and environmental health at risk.

In view of these elements, Parliament asked the Commission to:

- to withdraw its draft implementing regulation and to submit a new draft to the Committee that takes into account the scientific evidence on the harmful properties of all the substances concerned, especially of chlorotoluron;

- to present draft implementing regulations to extend the approval periods of substances for which the current state of science is not expected to lead to a Commission proposal for non-renewal of the authorisation of the active substance concerned;

- to withdraw the approvals for substances if proof or reasonable doubt exists that they will not meet the safety criteria laid down in Regulation (EC) No 1107/2009.

Member States are required to ensure the proper and timely reassessment of the authorisations of the active substances for which they are the reporting Member States and to ensure that the current delays are solved effectively as soon as possible.

Documents
2019/10/10
   EP - End of procedure in Parliament
2019/09/12
   EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI

Documents

Votes

B9-0104/2019 - Proposition de résolution

2019/10/10 Outcome: +: 417, -: 200, 0: 40
FR IT ES BG GB BE PT AT SK RO EL CY MT LV HR DK SI IE EE SE LT DE LU FI NL CZ HU PL
Total
66
65
44
14
64
18
21
15
12
24
18
6
6
8
10
12
7
10
3
19
10
86
5
12
26
19
17
40
icon: S&D S&D
139

Greece S&D

2

Cyprus S&D

2

Latvia S&D

2

Slovenia S&D

For (1)

1

Estonia S&D

For (1)

1

Lithuania S&D

2

Finland S&D

1

Hungary S&D

2
icon: Verts/ALE Verts/ALE
68

Spain Verts/ALE

2

Belgium Verts/ALE

3

Portugal Verts/ALE

1

Austria Verts/ALE

2

Latvia Verts/ALE

1

Denmark Verts/ALE

2

Ireland Verts/ALE

For (1)

1

Sweden Verts/ALE

2

Lithuania Verts/ALE

2

Luxembourg Verts/ALE

For (1)

1

Finland Verts/ALE

2

Netherlands Verts/ALE

3

Czechia Verts/ALE

3
icon: GUE/NGL GUE/NGL
38

United Kingdom GUE/NGL

1

Belgium GUE/NGL

For (1)

1

Cyprus GUE/NGL

2

Denmark GUE/NGL

1

Sweden GUE/NGL

For (1)

1

Finland GUE/NGL

For (1)

1

Netherlands GUE/NGL

For (1)

1

Czechia GUE/NGL

1
icon: ID ID
63

Belgium ID

2

Austria ID

2

Denmark ID

Against (1)

1

Finland ID

2

Czechia ID

For (1)

Abstain (1)

2
icon: Renew Renew
94

Belgium Renew

Against (1)

3

Austria Renew

For (1)

1

Slovakia Renew

2

Latvia Renew

For (1)

1

Croatia Renew

For (1)

1

Denmark Renew

4

Slovenia Renew

For (1)

Abstain (1)

2

Ireland Renew

For (1)

1

Estonia Renew

2

Sweden Renew

3

Lithuania Renew

2

Luxembourg Renew

For (1)

Against (1)

2

Finland Renew

For (1)

3

Hungary Renew

2
icon: NI NI
48

Slovakia NI

2

Croatia NI

1

Germany NI

1

Hungary NI

1
icon: ECR ECR
49

Italy ECR

3

Spain ECR

2

Bulgaria ECR

2

Belgium ECR

2

Slovakia ECR

2

Greece ECR

Against (1)

1

Latvia ECR

2

Croatia ECR

For (1)

1
3

Lithuania ECR

Against (1)

1

Netherlands ECR

4
icon: PPE PPE
158

Belgium PPE

Against (1)

4
2

Malta PPE

2

Latvia PPE

2

Croatia PPE

For (1)

4

Denmark PPE

Against (1)

1

Slovenia PPE

Against (1)

4

Ireland PPE

Abstain (1)

4

Luxembourg PPE

Against (1)

2

Finland PPE

3

History

(these mark the time of scraping, not the official date of the change)

docs/0/docs/0/url
http://www.europarl.europa.eu/doceo/document/B-9-2019-0104_EN.html
docs/1
date
2019-10-10T00:00:00
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0027 title: T9-0027/2019
type
Text adopted by Parliament, single reading
body
EP
events/0
date
2019-10-10T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/doceo/document/TA-9-2019-0027_EN.html title: T9-0027/2019
summary
events/0
date
2019-10-10T00:00:00
type
Decision by Parliament, 1st reading/single reading
body
EP
docs
url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0027 title: T9-0027/2019
docs
  • date: 2019-10-10T00:00:00 docs: title: B9-0104/2019 type: Motion for a resolution body: EP
  • date: 2019-10-10T00:00:00 docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0027 title: T9-0027/2019 type: Text adopted by Parliament, single reading body: EP
events
  • date: 2019-10-10T00:00:00 type: Decision by Parliament, 1st reading/single reading body: EP docs: url: http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference=P9-TA-2019-0027 title: T9-0027/2019
  • date: 2019-10-10T00:00:00 type: End of procedure in Parliament body: EP
procedure/stage_reached
Old
Awaiting Parliament 1st reading / single reading / budget 1st stage
New
Procedure completed
forecasts
  • date: 2019-10-10T00:00:00 title: Vote scheduled
forecasts/0/title
Old
Vote in plenary scheduled
New
Vote scheduled
forecasts/0/title
Old
Indicative plenary sitting date, 1st reading/single reading
New
Vote in plenary scheduled
procedure/title
Old
Objection pursuant to Rule 112: Extension of the approval periods of the active substances amidosulfuron, beta cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron (D062951)
New
Resolution on the draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron